Quick Takeaways
- CITADEL ADVISORS LLC filed SCHEDULE 13G for Corbus Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (the "Shares") (CRBP).
- Disclosed ownership: 5.3%.
- Date of event: 04 Nov 2025.
Quoteable Key Fact
"CITADEL ADVISORS LLC disclosed 5.3% ownership in Corbus Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (the "Shares") (CRBP) on 04 Nov 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Citadel Advisors LLC | 4.7% | 873,313 | 0 | 873,313 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Advisors Holdings LP | 4.7% | 873,313 | 0 | 873,313 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel GP LLC | 4.7% | 873,313 | 0 | 873,313 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities LLC | 0.6% | 107,297 | 0 | 107,297 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities Group LP | 0.6% | 107,297 | 0 | 107,297 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities GP LLC | 0.6% | 107,297 | 0 | 107,297 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Kenneth Griffin | 5.3% | 980,610 | 0 | 980,610 | /s/ Seth Levy | Seth Levy, attorney-in-fact* |